You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 27, 2024

Investigational Drug Information for HSK3486

✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug HSK3486?

HSK3486 is an investigational drug.

There have been 29 clinical trials for HSK3486. The most recent clinical trial was a Phase 3 trial, which was initiated on February 11th 2021.

The most common disease conditions in clinical trials are Liver Diseases, Renal Insufficiency, Chronic, and Renal Insufficiency. The leading clinical trial sponsors are Sichuan Haisco Pharmaceutical Group Co., Ltd., Sichuan Haisco Pharmaceutical Group Co., Ltd, and Haisco-USA Pharmaceuticals, Inc.

There are two US patents protecting this investigational drug and thirty-seven international patents.

Recent Clinical Trials for HSK3486
Comparison of Ciprofol-based and Propofol-based Total Intravenous Anesthesia on Postoperative Quality of RecoveryXijing HospitalN/A
Safety and Efficacy of HSK3486 Compares to Propofol for Induction of General Anesthesia in Adults With Elective SurgeryHaisco-USA Pharmaceuticals, Inc.Phase 3
Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant UsersHaisco-USA Pharmaceuticals, Inc.Phase 1

See all HSK3486 clinical trials

Clinical Trial Summary for HSK3486

Top disease conditions for HSK3486
Top clinical trial sponsors for HSK3486

See all HSK3486 clinical trials

US Patents for HSK3486

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
HSK3486 ⤷  Sign Up Use of GABAA receptor reinforcing agent in preparation of sedative and anesthetic medicament HAISCO CHENGDU PHARMACEUTICAL TECHNOLOGY CO., LTD. (Chengdu, Sichuan, CN) ⤷  Sign Up
HSK3486 ⤷  Sign Up Phenol derivative and preparation method and use in medicine thereof Sichuan Haisco Pharmaceutical Co., Ltd. (Chengdu, CN) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for HSK3486

Drugname Country Document Number Estimated Expiration Related US Patent
HSK3486 Australia AU2015311394 2034-09-04 ⤷  Sign Up
HSK3486 Brazil BR112017004448 2034-09-04 ⤷  Sign Up
HSK3486 Canada CA2959812 2034-09-04 ⤷  Sign Up
HSK3486 China CN105579034 2034-09-04 ⤷  Sign Up
HSK3486 Eurasian Patent Organization EA035649 2034-09-04 ⤷  Sign Up
HSK3486 Eurasian Patent Organization EA201790525 2034-09-04 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.